NMT Medical StarFlex Headache Prevention Study Ahead Of Schedule

NMT Medical expects to complete patient enrollment for its MIST trial, evaluating the firm's StarFlex septal repair device's ability to prevent migraine headaches, in Q3 2005, President & CEO John Ahern stated in a recent investor call